Literature DB >> 12584613

[Percutaneous radiofrequency ablation -- clinical indications and results].

J Tacke1.   

Abstract

Percutaneous interstitial tumor ablation therapy is a relatively new and steadily growing field within interventional radiology. Radiofrequency ablation (RFA) became one of the most accepted techniques among hyperthermal ablation procedures, presumably due to its superior relation between probe diameter and efficacy. The first part of this review provided an overview of the underlying principles, technical background and application techniques. This second part describes the indications, techniques and results of clinical RFA applied to primary and secondary liver tumors as well as experiences with extrahepatic RFA applied to kidney, bone and lung, together with a discussion of the current literature.

Entities:  

Mesh:

Year:  2003        PMID: 12584613     DOI: 10.1055/s-2003-37226

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  7 in total

Review 1.  Interventional MDCT.

Authors:  Thomas J Vogl; Joern O Balzer; Martin G Mack; Christopher Herzog
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

2.  Comparison of four radiofrequency ablation systems at two target volumes in an ex vivo bovine liver model.

Authors:  Hendrik Rathke; Bernd Hamm; Felix Güttler; Joern Rathke; Jens Rump; Ulf Teichgräber; Maximilian de Bucourt
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

3.  [Effectiveness of radiofrequency ablation of lung tumours ].

Authors:  K-H Schultheis; R Schroeder-Finckh; A Schultheis; R Kappes; F Sommerer; A Tannapfel
Journal:  Chirurg       Date:  2008-10       Impact factor: 0.955

4.  [Current concepts and recent developments of laser ablation in tumor therapy].

Authors:  C Stroszczynski; G Gaffke; M Gnauck; R Puls; N Hosten; U Speck; J Ricke; H Oettle; P Hohenberger; R Felix
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

Review 5.  [Percutaneous radiofrequency ablation of renal cell cancer].

Authors:  J Tacke; A H Mahnken
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

6.  [Radiofrequency ablation of lung tumors and -metastases].

Authors:  R T Hoffmann; T F Jakobs; M F Reiser; T K Helmberger
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

Review 7.  [Combined therapies including interventional radiology].

Authors:  S Clasen; P L Pereira
Journal:  Radiologe       Date:  2007-12       Impact factor: 0.803

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.